MAVEN INCOME & GROWTH VCT PLC

Report Publication Announcement • Jan 23, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8093N

Maven Income & Growth VCT PLC

23 January 2019

Maven Income and Growth VCT PLC (the Company)

Offer for Subscription

23 January 2019

On 26 September 2018, the Company and Maven Income and Growth VCT 5 PLC announced the publication of a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription of new Ordinary Shares of 10p each (together the "Offers" and each an "Offer").

The Board is pleased to advise that, with valid subscriptions received to date under the Company's Offer now approaching its initial fundraising target of £15 million, and in view of continued interest from potential investors, the Directors have resolved to utilise the over-allotment facility, as provided for under the terms and conditions of the Offers, to the extent required to meet further investor demand.

The Offer is expected to close by no later than 12.00 noon on 3 April 2019 in relation to the tax year 2018/19 and 12.00 noon on 26 April 2019 in relation to the tax year 2019/20 (unless the Offer is fully subscribed by an earlier date or previously extended by the Board to a date no later than 16 September 2019).

Downloadable versions of the Prospectus documents are available from the Company's website at: http://www.mavencp.com/migvct.

Any enquiries in respect of the Offer, or requests for copies of the Prospectus documents (available free of charge), should be directed to:

Maven Capital Partners UK LLP

Kintyre House

205 West George Street

Glasgow

G2 2LW

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

Maven Capital Partners UK LLP

Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

STRCKBDKOBKDDDB